Their ages ranged from 16 to 60 years (average 26 3). 64 patients were from the United Kingdom, sixteen from the West Indies, four from Eire, and one from Cyprus. There was a previous history of sexually acquired disease in 24. The duration of the discharge varied from 1 to 28 days (average 4 4).
The initial diagnosis was made by finding intracellular Gram-negative diplococci in a smear of the urethral discharge. A swab of the discharge was collected into Cooper's transport medium (Cooper, Mayr-Harting, and McLachlan, 1950) and sent to the Public Health Laboratory. Cultural confirmation of the diagnosis was made in 65 (76 5 per cent.) patients; this low rate was later found to be due to the transport medium which has now been replaced by Stuart's medium.
Every patient had routine serological tests for syphilis performed, and only in one West Indian patient were they positive.
Of the first series of 39 patients, 35 had blood taken for gentamicin assay 1 hour after either the first or second injection. Of the second series of 46 patients, 22 had samples of blood taken at varying times after the injection. Assays were performed by the Microbiological Laboratory of Roussel Laboratories Ltd. and by the Department of Microbiology, Southmead Hospital, Bristol.
Each patient had a repeat urethral swab and smear taken 1 week after treatment; at subsequent visits a smear was taken if any discharge was present. Not all patients attended for the full follow-up period (see Tables I and II) . Sera for gentamicin assay were tested by a method described elsewhere (McLaughlin and Reeves, 1971; Reeves, 1972) .
Results
Tables I and II show that the failure rate among those who attended for follow-up in each series was fairly high, four out of 38 (10 5 Although a great deal of information on the pharmacology of gentamicin has been published, little is known of the blood levels attained after such large single doses given to adults. In a small number of patients receiving 240 or 280 mg. intramuscularly (3-61 to 5-71 mg./kg.), Felarca and others (1971) found mean gentamicin serum levels of 14-0 jig./ml. at 30 min., 13.1 4sg./ml. at 60 min., and 8-1 ,±g./ml. at 120 min. after injection. Our own results suggest a mean peak value of rather less (Table IV) , but are similar with regard to the timing of the rise. The similarity of mean serum levels at 30 and 60 min. in their results, and for the time periods 16-30 and 31-45 min. in our results, suggests that either the dose response curve is very flat or there is wide variation in the timing of the peak. Personal observations favour the latter, as do the results of Hantschke and others (1973), although Riff and Jackson (1971) have suggested that some patients may have a flat response curve.
Assuming the half-life of gentamicin to be about 2 hrs in patients with normal renal function, then the blood gentamicin concentration would be above the highest MIC of any of our strains of N. gonorrhoeae (i.e. 2 ,ug./ml.) for approximately 3 hrs after doses of 120 mg. and for 5 hrs after doses of 240 mg.
Although we did not attempt to detect objectively any ototoxicity caused by gentamicin, published evidence suggests that it should not arise when only one or two doses of this size are given. Senra del Valle, Imbrogno, and Fernandez (1969) gave 4 to 6 mg./kg. daily to children with no ill effects, while Wersall, Lundquist, and Bjorkroth (1969) were of the opinion that levels of 12 [*g./ml. in the blood were acceptable provided the drug was rapidly excreted and that the dose was not repeated. These clinical observations fit in well with experimental observations of animals which show that diffusion of aminoglycoside antibiotics into the perilymph and endolymph of the inner ear is slow (Stupp, Rauch, Sous, and Lagier, 1966) . Clinical studies with streptomycin also suggest that ototoxicity depends mainly on the more prolonged 'trough' levels rather than on transitory 'peak' levels. (Line, Poole, and Waterworth, 1970) . 
